Home > Boards > US Listed > Biotechs > Aravive - Oncology/Biotech Company (ARAV)

hope you do well on your mid 9's

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
[SMART MONEY]  Member Profile
Member Level 
Followed By 3,394
Posts 127,581
Boards Moderated 28
Alias Born 08/05/09
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2020 4:06:43 PM
Aravive To Present at The 2020 RBC Capital Markets Global Healthcare Conference GlobeNewswire Inc. - 5/12/2020 8:00:10 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2020 4:19:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2020 4:12:05 PM
Aravive Reports First Quarter 2020 Financial Results and Provides Recent Corporate Updates GlobeNewswire Inc. - 5/6/2020 4:05:10 PM
Aravive and WuXi Biologics Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer... GlobeNewswire Inc. - 4/30/2020 8:00:10 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 4/16/2020 6:02:41 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/10/2020 4:30:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2020 4:44:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2020 4:11:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2020 4:08:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2020 4:06:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2020 4:06:16 PM
Aravive Announces Board Composition and Executive Management Transitions GlobeNewswire Inc. - 4/9/2020 7:08:32 AM
Aravive Announces AVB-500 Improves Anti-Tumor Effects when Combined with Anti-Angiogenic Bevacizumab or PARP Inhibitor Olapar... GlobeNewswire Inc. - 3/30/2020 8:00:10 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/27/2020 8:39:09 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/27/2020 8:13:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/27/2020 8:07:16 AM
Aravive Reports Fourth Quarter and Twelve Months Ended December 31, 2019 Financial Results and Provides Recent Corporate Upda... GlobeNewswire Inc. - 3/27/2020 8:00:10 AM
Aravive Announces Initiation of Investigator-Sponsored Phase 1/2 Study of AVB-500 in Combination with Avelumab in Patients wi... GlobeNewswire Inc. - 3/24/2020 8:00:10 AM
Aravive To Present at The Cowen and Company 40th Annual Health Care Conference GlobeNewswire Inc. - 2/25/2020 4:07:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/18/2020 8:12:10 AM
Aravive Announces Dose Escalation of AVB-500 in Recurrent Platinum Resistant Ovarian Cancer Phase 1b Trial GlobeNewswire Inc. - 2/18/2020 8:00:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 6:08:35 AM
Aravive Receives IND Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinom... GlobeNewswire Inc. - 1/13/2020 8:00:10 AM
[SMART MONEY] Member Level  Thursday, 11/21/19 06:23:07 AM
Re: Actualfactual post# 32
Post # of 47 
hope you do well on your mid 9's


as long as there isnt any offerings




Always consult an Investment Professional, all communications
about stocks from me are my own opinions, and not for investing
decisions
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist